Skip to content

Our Care Wishes - Dementia

Adaptation of the OurCareWishes.Org ACP Platform for Persons With Dementia in NHs and Their Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05033262
Enrollment
14
Registered
2021-09-02
Start date
2020-10-07
Completion date
2021-09-08
Last updated
2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Dementia, Memory Impairment

Keywords

Advance Care Planning, Shared Decision-Making, Web-Based Platform, Memory Care, Nursing Homes

Brief summary

This Our Care Wishes- Dementia pilot study is adapting an existing successful online advance care planning platform to the specific needs of persons living with dementia and shared decision-makers (SDMs) and testing the usability and acceptability among nursing home residents and SDMs.

Interventions

OTHEROur Memory Care Wishes

Our Memory Care Wishes is a web-based advance care planning platform designed for persons living with dementia in nursing homes to discuss and document healthcare and daily life preferences with the help of shared decision-makers. Penn researchers meet via Zoom with PLWD and their SDMS and nursing home staff to facilitate website completion.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Eligible PLWD will be receiving short-or long-term care at a participating NH, have documented moderate to severe cognitive impairment as measured by the Cognitive Function Scale included in the Minimum Data Set 3.0, 65 and have an identified SDM.

Exclusion criteria

* Participants are not eligible discharged from participating NHs, or do not have access to a telephone or video chat.

Design outcomes

Primary

MeasureTime frameDescription
Adapted Decision Making Confidence ScaleBaselineItems from the Surrogate Decision-Making Confidence Scale and 9-item ACP Engagement Survey were used and adapted to capture the confidence in advanced care planning decision-making from both persons living with dementia and their shared decision-maker' points of view. The scale utilizes a Likert scale with values ranging from 1 (not confident at all) to 5 (very confident).
Post Adapted Decision Making Confidence Scale1 weekItems from the Surrogate Decision-Making Confidence Scale and 9-item ACP Engagement Survey were used and adapted to capture the confidence in advanced care planning decision-making from both persons living with dementia and their shared decision-maker' points of view. The scale utilizes a Likert scale with values ranging from 1 (not confident at all) to 5 (very confident). This is the second time point the measure was collected.
Website Ease of Use1 weekThis scale measures the ease of use of the website. This scale uses a Likert scale from 0 (very hard) to 10 (very easy). These data were collected from PLWDs and SDMs in the intervention group.
Rate of ACP Website Completion - Time1 weekThis tool measured total time spent by participants on the advance care planning website. Total time in minutes spent on the website were collected. Because SDMs navigated the website with the PLWD alongside them, this measure was only used to SDMs in the intervention group.
Rate of ACP Website Completion - Questions Completed1 weekThis tool measured what percentage of the website was completed by participants. Because SDMs navigated the website with the PLWD alongside them, this measure was only associated with SDMs in the intervention group.

Other

MeasureTime frameDescription
COVID-19 Impact Questionnaire1 weekParticipants were asked if their healthcare preferences changed due to the COVID-19 pandemic. Items included: 1. Since COVID, planning for the future is: (1) less important (2) more important, or (3) the same 2. Since COVID, the sense of urgency to name a supportive decision maker has: (1) increased (2) decreased, or (3) remained the same. 3. Since COVID, my preferences for decisions about breathing machines (ventilators) have: (1) changed or (2) remained the same. 4. Since COVID, my preferences for going to the hospital for care versus receiving treatment in place have:(1) changed, or (2) remained the same.

Countries

United States

Participant flow

Recruitment details

Dyads (i.e., persons living with dementia (PLWD) and their shared decision-makers (SDMS) were initially recruited by nursing home staff. Then, study staff read an assent script to and reviewed study procedures with interested SDMs. SDMs who agreed to participate were sent a copy of the study summary and assent script. After verbal assent was acquired, dyads (PLWDs and SDMs) were assigned to the intervention group or control arm.

Pre-assignment details

Enrolled participants are organized into 4 individual groups: PLWDs & SDMs in the intervention and control arms. Dyads in all study arms who stopped answering study team calls after initial verbal telephone consent and did not complete the baseline interview were not considered enrolled and are excluded from the Baseline & Follow Up Surveys period below. Demographics were collected during the baseline interview. Nursing home staff were not enrolled in the study.

Participants by arm

ArmCount
PLWD: Control
Participants living with dementia randomized to the control group will receive usual advanced care planning help from nursing facility staff and will not complete the Our Memory Care Wishes website. Participants will complete surveys that capture confidence in decision-making at baseline and 1 week. Participants will complete these surveys alongside their shared decision makers.
3
SDMs: Control
Shared decision-makers of persons living with dementia randomized to the control group will work with their care receiver to have usual advanced care planning discussions with nursing facility staff. SDMs in the control group will not complete the Our Memory Care Wishes website. SDMs will complete surveys that capture confidence in decision-making at baseline and 1 week. SDMs will complete these surveys alongside the nursing home resident they care for.
3
PLWD: Intervention
Persons living with dementia (PLWD) randomized to the intervention group will complete a baseline interview alongside their shared decision-maker (SDM) that collects demographics and their confidence in decision-making. Then PLWDs will work with their SDM to complete the Our Memory Care Wishes website with the PLWD. Our Memory Care Wishes is a web-based advance care planning platform designed for persons living with dementia in nursing homes to discuss and document healthcare and daily life preferences with the help of shared decision-makers. 1 week after completing the website, PLWDs will complete a follow up interview collecting their confidence in decision-making, ratings of the website and how COVID has affected their decision-making.
4
SDMs: Intervention
Shared decision-makers (SDMs) of persons living with dementia (PLWD) randomized to the intervention group will complete a baseline interview that collects demographics and their confidence in decision-making when it comes to being a surrogate for the PLWD. Then, SDMs will complete the Our Memory Care Wishes website with the PLWD. Our Memory Care Wishes is a web-based advance care planning platform designed for persons living with dementia in nursing homes to discuss and document healthcare and daily life preferences with the help of shared decision-makers. 1 week after completing the website, SDMs will complete a follow up interview collecting their confidence in decision-making, ratings of the website and how COVID has affected their decision-making.
4
Total14

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Overall StudyLost to Follow-up1001

Baseline characteristics

CharacteristicPLWD: ControlSDMs: ControlPLWD: InterventionSDMs: InterventionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants2 Participants4 Participants2 Participants11 Participants
Age, Categorical
Between 18 and 65 years
0 Participants1 Participants0 Participants2 Participants3 Participants
Age, Continuous78.6 years64 years89.3 years65.5 years74.8 years
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants1 Participants0 Participants0 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants2 Participants4 Participants4 Participants12 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants1 Participants1 Participants2 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants0 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
2 Participants2 Participants3 Participants3 Participants10 Participants
Region of Enrollment
United States
3 participants3 participants4 participants4 participants14 participants
Sex: Female, Male
Female
1 Participants2 Participants2 Participants3 Participants8 Participants
Sex: Female, Male
Male
2 Participants1 Participants2 Participants1 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 8
other
Total, other adverse events
0 / 60 / 8
serious
Total, serious adverse events
0 / 60 / 8

Outcome results

Primary

Adapted Decision Making Confidence Scale

Items from the Surrogate Decision-Making Confidence Scale and 9-item ACP Engagement Survey were used and adapted to capture the confidence in advanced care planning decision-making from both persons living with dementia and their shared decision-maker' points of view. The scale utilizes a Likert scale with values ranging from 1 (not confident at all) to 5 (very confident).

Time frame: Baseline

Population: SDMs and PLWDs in all study arms that completed the baseline interview were analyzed.

ArmMeasureValue (MEAN)
PLWD: ControlAdapted Decision Making Confidence Scale4.8 score on a scale
SDMs: ControlAdapted Decision Making Confidence Scale4.7 score on a scale
PLWDs: InterventionAdapted Decision Making Confidence Scale3.7 score on a scale
SDMs: InterventionAdapted Decision Making Confidence Scale5 score on a scale
Primary

Post Adapted Decision Making Confidence Scale

Items from the Surrogate Decision-Making Confidence Scale and 9-item ACP Engagement Survey were used and adapted to capture the confidence in advanced care planning decision-making from both persons living with dementia and their shared decision-maker' points of view. The scale utilizes a Likert scale with values ranging from 1 (not confident at all) to 5 (very confident). This is the second time point the measure was collected.

Time frame: 1 week

Population: 1 PLWD from the control group and 1 SDM from the Intervention group were lost to follow up. Data was not collected at this timepoint and so were not analyzed.

ArmMeasureValue (MEAN)
PLWD: ControlPost Adapted Decision Making Confidence Scale4.9 units on a scale
SDMs: ControlPost Adapted Decision Making Confidence Scale4.7 units on a scale
PLWDs: InterventionPost Adapted Decision Making Confidence Scale4.25 units on a scale
SDMs: InterventionPost Adapted Decision Making Confidence Scale5 units on a scale
Primary

Rate of ACP Website Completion - Questions Completed

This tool measured what percentage of the website was completed by participants. Because SDMs navigated the website with the PLWD alongside them, this measure was only associated with SDMs in the intervention group.

Time frame: 1 week

Population: Percentage of website completed was captured for SDMs as they were primary navigators of the website.

ArmMeasureValue (MEAN)
PLWD: ControlRate of ACP Website Completion - Questions Completed69 percentage of website completed
Primary

Rate of ACP Website Completion - Time

This tool measured total time spent by participants on the advance care planning website. Total time in minutes spent on the website were collected. Because SDMs navigated the website with the PLWD alongside them, this measure was only used to SDMs in the intervention group.

Time frame: 1 week

Population: Total time SDMs spent navigating the Our Memory Care Wishes website was captured for each SDM in the intervention group.

ArmMeasureValue (MEAN)
PLWD: ControlRate of ACP Website Completion - Time42.93 minutes
Primary

Website Ease of Use

This scale measures the ease of use of the website. This scale uses a Likert scale from 0 (very hard) to 10 (very easy). These data were collected from PLWDs and SDMs in the intervention group.

Time frame: 1 week

Population: SDMs tended to navigate the website and use the website to facilitate advanced care planning discussions with PLWDs. PLWDs participated in conversations about advanced care planning decisions but often did not actively use the website and so were not always able to answer or understand the questions regarding the website. In the end, only one PLWD from the intervention group was able to answer the questions about the website's ease of use. Thus, the score below indicates that PLWD's rating.

ArmMeasureValue (MEAN)
PLWD: ControlWebsite Ease of Use7 score on a scale
SDMs: ControlWebsite Ease of Use9 score on a scale
Other Pre-specified

COVID-19 Impact Questionnaire

Participants were asked if their healthcare preferences changed due to the COVID-19 pandemic. Items included: 1. Since COVID, planning for the future is: (1) less important (2) more important, or (3) the same 2. Since COVID, the sense of urgency to name a supportive decision maker has: (1) increased (2) decreased, or (3) remained the same. 3. Since COVID, my preferences for decisions about breathing machines (ventilators) have: (1) changed or (2) remained the same. 4. Since COVID, my preferences for going to the hospital for care versus receiving treatment in place have:(1) changed, or (2) remained the same.

Time frame: 1 week

Population: 1 PLWD in the control group was lost to follow up.~1 SDM in the control group was lost to follow up.~1 PLWD in the intervention group was lost to follow up.~1 SMD in the intervention group was lost to follow up.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
PLWD: ControlCOVID-19 Impact QuestionnaireParticipants who reported a change in importance level for planning for the future since COVID-19.1 Participants
PLWD: ControlCOVID-19 Impact QuestionnaireChange in the sense of urgency to name a supportive decision maker since COVID-190 Participants
PLWD: ControlCOVID-19 Impact QuestionnaireParticipants who reported a change in breathing machine preferences since COVID-19.0 Participants
PLWD: ControlCOVID-19 Impact QuestionnaireParticipants whose preferences for going to the hospital for care versus receiving treatment changed0 Participants
SDMs: ControlCOVID-19 Impact QuestionnaireChange in the sense of urgency to name a supportive decision maker since COVID-192 Participants
SDMs: ControlCOVID-19 Impact QuestionnaireParticipants who reported a change in breathing machine preferences since COVID-19.1 Participants
SDMs: ControlCOVID-19 Impact QuestionnaireParticipants whose preferences for going to the hospital for care versus receiving treatment changed1 Participants
SDMs: ControlCOVID-19 Impact QuestionnaireParticipants who reported a change in importance level for planning for the future since COVID-19.1 Participants
PLWDs: InterventionCOVID-19 Impact QuestionnaireParticipants who reported a change in breathing machine preferences since COVID-19.0 Participants
PLWDs: InterventionCOVID-19 Impact QuestionnaireChange in the sense of urgency to name a supportive decision maker since COVID-190 Participants
PLWDs: InterventionCOVID-19 Impact QuestionnaireParticipants whose preferences for going to the hospital for care versus receiving treatment changed0 Participants
PLWDs: InterventionCOVID-19 Impact QuestionnaireParticipants who reported a change in importance level for planning for the future since COVID-19.1 Participants
SDMs: InterventionCOVID-19 Impact QuestionnaireParticipants whose preferences for going to the hospital for care versus receiving treatment changed1 Participants
SDMs: InterventionCOVID-19 Impact QuestionnaireChange in the sense of urgency to name a supportive decision maker since COVID-191 Participants
SDMs: InterventionCOVID-19 Impact QuestionnaireParticipants who reported a change in importance level for planning for the future since COVID-19.1 Participants
SDMs: InterventionCOVID-19 Impact QuestionnaireParticipants who reported a change in breathing machine preferences since COVID-19.1 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026